Achilles Tendinopathy
Conditions
Keywords
Achilles Tendinopathy, Ultrasonography, Resistance Training
Brief summary
This work is designed as a prospective cohort study, in which the effects of a protocol of 12-week resistance training loading the Achilles tendon in patients with Achilles tendinopathy (AT) will be monitored. It is estimated that at least 20 patients will participate. In addition, there will be a small control group of healthy participants which will not complete the same protocol, but will be monitored for natural changes in same objectives. Group of patients will be instructed to perform a training protocol.
Detailed description
The research within one participant will last a total of 26 weeks from the initial to the final examination and will include control measurements at 6 and 12 weeks from the beginning of therapy. Potential participants will be selected based on the recommendation of a specialist doctor and their suitability will be assessed according to the inclusion criteria. They will then be invited to an initial examination. This will include an objective examination by a physiotherapist, a subjective assessment by the patient and an ultrasonographic (USG) examination followed by a micromorphological analysis using special software. At the end of the initial examination, the participant will be informed about training protocol.
Interventions
It is a 12-week Silbernagel ankle dorsiflexion resistance training protocol. It is a series of exercises with a gradual progression of load according to defined criteria, which the patient practices every day.
Sponsors
University Hospital, Motol
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* the patient shows symptoms of Achilles tendinopathy (pain, swelling and dysfunction in the area of Achilles tendon), which at least partially limit his quality of life during normal or sporting activities, * the patient is in the age group of 18-60 years, * the patient has difficulties in only one lower limb; the second, asymptomatic limb will be considered the reference, * the patient is not aware of any mechanical damage to the tendon in symptomatic limb in the past (e.g. partial or complete rupture as a result of an injury), * the patient has not undergone any treatment aimed at AS in the last 3 months (surgery, corticoid application, plasma therapy, shock waves, physiotherapy, etc.), objective US examination of AS shows structural changes (expansion, neovascularization, focal hypoechoic areas, etc.).
Exclusion criteria
* patient has been diagnosed with a rheumatic disease or a disease of the central nervous system * patient is aware of mechanical damage to the Achilles tendon as a result of an injury in the past.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Peak Spatial Frequency Radius at the site of Pathology | Change of initial values at 26 weeks follow up after beginning of the therapy. | Measured by spatial frequency analysis software from ultrasound picture in mm-1. In a linear view with specific settings of ultrasound machine, the site of the largest pathology is selected, then the image is saved and uploaded to the software that evaluates the PSFR parameter. |
| Change in Tendon Diameter at the Place of Maximum Tendon Width | Change of initial values at 26 weeks follow up after beginning of the therapy. | Measured by tools in ultrasound machine in mm2. In linear view is selected maximal width place, then the tendon diameter is measured using device tools. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in VISA-A Questionnaire Score | Change of initial values at 39 weeks follow up after beginning of the therapy. | The VISA-A questionnaire is standardized questionnaire for patients with Achilles tendinopathy. The results are recorded in points (0-100 points). The higher score indicates patients better condition. |
Countries
Czechia
Contacts
STUDY_CHAIRStanislav Machac, PhD
University Hospital Motol and 2nd Faculty of Medicine, Charles University
Outcome results
None listed